Because PMAX lacks a meaningful set of attributable, current analyst price targets, this discussion does not rely on a calculated analyst consensus. MarketBeat shows no consensus price target for the stock, and Benzinga similarly reports that no consensus target is available. The one formal rating that appears, from Weiss Ratings, carries a "Sell (E+)" designation and no numeric target. TipRanks' AI analyst Spark assigns a Neutral stance with a $2.50 target, but that is an automated view rather than a sell-side estimate.
Accordingly, the $1.00 figure used here comes from public discussion and an identifiable technical-regulatory milestone: the Nasdaq Capital Market's $1.00 minimum bid price requirement. Powell Max itself disclosed that its April 2026 1-for-10 reverse stock split was undertaken specifically to lift the share price above that threshold. This makes $1.00 a genuine, widely discussed objective rather than an invented headline figure. From what I see, this regulatory context gives the level real weight for anyone following the name.
At a latest verified price of about $0.86, PMAX sits below the $1.00 level despite the recent reverse split. Reaching $1.00 would require an advance of roughly 16%, a modest move in percentage terms but one that has proven elusive for a company that has struggled to sustain its share price. The stock's 52-week range — approximately $0.45 to $33.50 on a split-adjusted basis — underscores extreme volatility.
The reported fundamentals are challenging. Trailing-twelve-month revenue of about $47.7 million is offset by a net loss near $23.5 million, negative EPS, and negative operating and free cash flow. A price-to-sales ratio well below 1 and an enterprise value only a fraction of revenue indicate the market is pricing in continued weakness and dilution risk rather than a near-term recovery. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how the stock compares to others in the industry.
The $1.00 level is the dominant psychological and regulatory resistance. Below it, the 50-day moving average near $0.81 has acted as nearby support, while the stock's split-adjusted 200-day average remains far above the current price, consistent with the long-running downtrend. The shares trade well off the 52-week high, and the recent RSI reading near the mid-50s offers no strong directional signal. A sustained move above $1.00, rather than a brief intraday poke, would be the more meaningful technical confirmation.
Because the $1.00 objective is a compliance milestone rather than a traditional 12-month analyst target, it carries no standard research horizon. Investors should instead monitor near-term catalysts: the company's next earnings report (currently estimated for late November 2026), any Nasdaq compliance notices or extension decisions, further dilutive financings or share issuances, and Hong Kong capital-markets activity. Analyst and AI rating changes, however sparse, also bear watching.
The $1.00 target for Powell Max Limited is not an analyst-derived price forecast but a real, publicly discussed regulatory milestone tied to the Nasdaq minimum bid requirement. From a latest price near $0.86, the required move is about 16%. Supporting the level are genuine revenue, management's listing-preservation incentive, and the reduced share count following the reverse split. Working against it are recurring losses, negative cash flow, dilution, and the stock's demonstrated inability to hold $1.00. With no credible sell-side consensus and only sparse, cautious ratings available, investors should watch earnings, Nasdaq compliance developments, and any new financing before drawing conclusions. No outcome — including a return to $1.00 — is guaranteed.
In my own research process, I find Tickeron's AI Daily Buy/Sell Signals helpful for tracking names like this one. The platform applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. It serves as a practical complement to manual analysis rather than a replacement, allowing users to spot changes more efficiently while maintaining their own perspective on the data.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Indicator for PMAX moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 9 instances where the indicator moved out of the overbought zone. In 9 of the 9 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
PMAX broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PMAX entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on PMAX as a result. In 35 of 43 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for PMAX just turned positive on October 28, 2026. Looking at past instances where PMAX's MACD turned positive, the stock continued to rise in 18 of 18 cases over the following month. The odds of a continued upward trend are 90%.
PMAX moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +84.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where PMAX advanced for three days, in 72 of 88 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.453) is normal, around the industry mean (3.120). P/E Ratio (-0.004) is within average values for comparable stocks, (6.734). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.976) among similar stocks. P/S Ratio (0.042) is also within normal values, averaging (16.899).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating steady price growth. PMAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InvestmentBanksBrokers